What is the name of the organization that established the Innovative Treatment Development Fund for Parkinson's disease research?

The Japan Private Trust Foundation, headquartered in Minato-ku, Tokyo, and led by Representative Director Takayuki Sato, established the Innovative Treatment Development Fund.

When will applications open for researchers seeking grants from the Innovative Treatment Development Fund?

Applications for grants from the Innovative Treatment Development Fund will begin on Monday, April 6, 2026.

What is the primary goal of the Innovative Treatment Development Fund in relation to Parkinson's disease?

The fund aims to support original research that achieves 'Disease Modification' by stopping disease progression or regenerating neurological functions in Parkinson's disease.

What are the four main research areas targeted by the Innovative Treatment Development Fund for Parkinson's disease?

The fund targets research in pathological elucidation, drug discovery and therapeutic development, diagnosis and biomarkers, and clinical medicine and translational research.

How much funding is allocated for the Innovative Fundamental Treatment Award and how many recipients will be selected?

The Innovative Fundamental Treatment Award offers a grant amount of 4 million yen to one recipient who is a Principal Investigator with outstanding achievements.

AI News NQ Analysis

Support for the challenge aiming for a 'complete cure' for Parkinson's disease. Announcement of the establishment of the 'Innovative Treatment Development Fund' and the start of grant applications.

NQ Score 100/100

AI Summary (NQ-processed)

The Japan Private Trust Foundation has launched the 'Innovative Treatment Development Fund' to support research aimed at a complete cure for Parkinson's disease, accepting grant applications from April 6, 2026. The fund allocates 10 million yen across two awards—the Innovative Fundamental Treatment Award (4 million yen) and the Young Investigator Challenge Encouragement Award (2 million yen for three recipients)—to back pioneering research in pathological elucidation, drug discovery, diagnosis, and clinical translation.

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the name of the organization that established the Innovative Treatment Development Fund for Parkinson's disease research?: A: The Japan Private Trust Foundation, headquartered in Minato-ku, Tokyo, and led by Representative Director Takayuki Sato, established the Innovative Treatment Development Fund.
Q: When will applications open for researchers seeking grants from the Innovative Treatment Development Fund?: A: Applications for grants from the Innovative Treatment Development Fund will begin on Monday, April 6, 2026.
Q: What is the primary goal of the Innovative Treatment Development Fund in relation to Parkinson's disease?: A: The fund aims to support original research that achieves 'Disease Modification' by stopping disease progression or regenerating neurological functions in Parkinson's disease.
Q: What are the four main research areas targeted by the Innovative Treatment Development Fund for Parkinson's disease?: A: The fund targets research in pathological elucidation, drug discovery and therapeutic development, diagnosis and biomarkers, and clinical medicine and translational research.
Q: How much funding is allocated for the Innovative Fundamental Treatment Award and how many recipients will be selected?: A: The Innovative Fundamental Treatment Award offers a grant amount of 4 million yen to one recipient who is a Principal Investigator with outstanding achievements.